Latest News

FDA Accepts BLA for Lerodalcibep, Novel PCSK9 Inhibitor to Lower LDL-C
FDA Accepts BLA for Lerodalcibep, Novel PCSK9 Inhibitor to Lower LDL-C

February 10th 2025

The FDA set a PDUFA action date of December 12, 2025 for lerodalcibep, according to LIB Therapeutics.

Investigators Identify Hemoglobin A1c/HDL-C as a Predictor of Stroke Risk in Older Adults
Investigators Identify Hemoglobin A1c/HDL-C as a Predictor of Stroke Risk in Older Adults

February 5th 2025

Roche Receives FDA 510(k) Clearance for First US Blood Test Measuring Lp(a) in Molar Units / Image credit: ©Sundry Photography/AdobeStock
Roche Receives FDA 510(k) Clearance for First US Blood Test Measuring Lp(a) in Molar Units

February 5th 2025

Propranolol May Lower Stroke Risk in Women with Migraine, Study Finds / Image credit: ©9nong/AdobeStock
Propranolol May Lower Stroke Risk in Women with Migraine, Study Finds

January 31st 2025

Furosemide Fails to Reduce Risk of Dangerous de novo Postpartum Hypertension: New Research / image credit ©javier/stock.adobe.com
Furosemide Fails to Reduce Risk of Dangerous de novo Postpartum Hypertension: New Research

January 30th 2025

© 2025 MJH Life Sciences

All rights reserved.